LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 93.92 | 21.74 | 39 | 6070 | 0.0064 | 0.0746 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 93.92 | 21.74 | 11016 | 6070 | 1.8148 | 1.1522 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 93.92 | 21.74 | 61 | 6070 | 0.0100 | 0.1354 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 93.92 | 21.74 | 14019 | 6070 | 2.3096 | 1.2170 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 2.24 | 21.74 | 1 | 183 | 0.0054 | -0.6323 | MN20160310_N01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 2.24 | 21.74 | 543 | 183 | 2.9580 | 1.8448 | MN20160310_N01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 2.24 | 21.74 | 3 | 183 | 0.0163 | -0.4745 | MN20160310_N01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 2.24 | 21.74 | 531 | 183 | 2.8926 | 1.8242 | MN20160310_N01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 4.24 | 21.74 | 1 | 317 | 0.0031 | -0.5487 | MN20160310_N01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 4.24 | 21.74 | 723 | 317 | 2.2751 | 1.4734 | MN20160310_N01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 4.24 | 21.74 | 6 | 317 | 0.0189 | -0.2830 | MN20160310_N01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 4.24 | 21.74 | 752 | 317 | 2.3664 | 1.4986 | MN20160310_N01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 6.21 | 21.74 | 1 | 392 | 0.0026 | -0.5219 | MN20160310_N01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 6.21 | 21.74 | 847 | 392 | 2.1607 | 1.4056 | MN20160310_N01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 6.21 | 21.74 | 11 | 392 | 0.0281 | -0.1506 | MN20160310_N01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 6.21 | 21.74 | 825 | 392 | 2.1046 | 1.3905 | MN20160310_N01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 8.19 | 21.74 | 1 | 439 | 0.0023 | -0.5082 | MN20160310_N01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 8.19 | 21.74 | 921 | 439 | 2.0939 | 1.3714 | MN20160310_N01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 8.19 | 21.74 | 8 | 439 | 0.0182 | -0.2058 | MN20160310_N01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 8.19 | 21.74 | 945 | 439 | 2.1484 | 1.3855 | MN20160310_N01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 10.16 | 21.74 | 1 | 463 | 0.0022 | -0.5022 | MN20160310_N01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 10.16 | 21.74 | 976 | 463 | 2.1051 | 1.3673 | MN20160310_N01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 10.16 | 21.74 | 20 | 463 | 0.0431 | -0.0187 | MN20160310_N01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 10.16 | 21.74 | 886 | 463 | 1.9110 | 1.3160 | MN20160310_N01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 12.13 | 21.74 | 1 | 496 | 0.0020 | -0.4945 | MN20160310_N01 | L18 |